Faron logo
VerifiedPharmaceutical Manufacturing· Founded 2007

Faron

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. Its lead program is bexmarilimab, its investigative precision immunotherapy in Phase I/II development as a novel macrophage checkpoint immunotherapy for patients with hematological malignancies. Bexmarilimab is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Faron is based in Turku, Finland and Boston, Massachusetts. Faron is listed on AIM under the ticker ‘FARN’ and Nasdaq First North Growth Market ("Nasdaq First North") under ticker FARON.

7-day free trial · no credit card

HeadquartersTurku, FinlandEmployees58(11 to 50)Founded year2007Websitefaron.comLinkedIn profileLinkedIn

Verified contacts

32

available on Kipplo

LinkedIn employees

58

11 to 50 range

Open roles

no listings

Distinct roles

25

indexed titles

Tech stack

1

tools in use

Monthly traffic

234

organic / mo

Sign up free to see all 32 verified contacts at Faron

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

32 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Faron

25 distinct titles indexed · top 10 shown.

  • 2administrative assistant
  • 2associate clinical trial manager
  • 2cmc specialist
  • 1() -
  • 1account specialist
  • 1business development manager
  • 1chief scientific officer
  • 1clinical trial associate
  • 1deputy general counsel
  • 1director, ir & funding
  • +15more titles

Sign up to unlock all 32 contacts at Faron

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 32 verified contacts at Faron

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Faron | Kipplo Discover